X-linked lymphoproliferative syndrome registry report

Area of Science:

• Immunology
• Virology
• Oncology

Background:

• X-linked lymphoproliferative syndrome (XLP) is a rare genetic disorder characterized by severe immune deficiency.
• Individuals with XLP exhibit extreme susceptibility to Epstein-Barr virus (EBV) infection, often leading to fatal outcomes.
• Cardinal features include susceptibility to infectious mononucleosis, acquired agammaglobulinemia, and lymphoma.

Purpose of the Study:

• To comprehensively study the spectrum of lymphoproliferative phenotypes in XLP.
• To investigate the role of EBV in the pathogenesis of XLP-associated conditions.
• To explore the potential oncogenic activity of EBV in immune-deficient XLP patients.

Main Methods:

• Analysis of data from 59 males with XLP across seven kindreds, collected by the XLP Registry since 1978.
• Comprehensive clinical and immunological evaluation of affected individuals.
• Assessment of EBV antibody status in relation to EBV infection and clinical presentation.

Main Results:

• A diverse range of lymphoproliferative phenotypes was observed in XLP patients.
• High mortality rates were associated with infectious mononucleosis (57%) and EBV-associated lymphoma (14%).
• Some XLP patients lacked EBV antibodies despite documented EBV infection, indicating immune dysregulation.

Conclusions:

• EBV infection can trigger a spectrum of severe lymphoproliferative disorders in individuals with XLP.
• EBV may act as an oncogenic agent in the context of XLP-induced immune deficiency.
• Understanding XLP and EBV interactions is crucial for managing these life-threatening conditions.